OncLive's FDA Approval Report: The Regulatory Rundown for March 2025 OncLive The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Is BPC 157 Legal? Understanding Its Status and Implications The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 Rapid 250mcg Pure Prescriptions Is BPC 157 Legal? Understanding Its Status and Implications